Emergent biomarkers for Alzheimer's disease (AD) are expected to provide earlier and more precise diagnoses. However, even if biomarkers live up to these expectations, it cannot be taken for granted that patients actually would value an earlier and more precise AD diagnosis. Based on an ...
Alzheimer’s disease Arthritis Lou Gehrig’s disease ( What Else Should I Know? If you think you have Lyme disease, it’s a good idea to see a board-certifiedinfectious disease specialist. This type of doctor is skilled in both diagnosis and treatment. The tests that look for Lyme disease...
Alcoholcan also worsen paranoia. Plus, it makes us less inhibited, which makes it harder to control these feelings. Memory loss Alzheimer’s disease and other forms ofdementia, which are more likely as you age, can changeyour brainin ways that make you more suspicious of others. You might ...
You cannot avoid a waiting period if you’ve been diagnosed with dementia or Alzheimer’s. Also, a waiting period is inevitable if you’ve ever been prescribed medications even once (even if you never took them) for memory problems. Full article about burial insurance with dementia Depression...
There is no cure for Alzheimer's, but there are treatments—from cognitive enhancers to non-drug approaches—to help manage it. Learn about the options.
9 Entertaining Activities for Low Vision Seniors with Alzheimer’s or Dementia This article wasn’t sponsored, but contains some affiliate links. If you buy through an affiliate link on our site, we may earn a small commission, at no additional cost to you, and we appreciate your support. ...
The use of Artificial Intelligence (AI) technology in the diagnosis of Alzheimer’s Disease. The difference between traditional methods of diagnosis and AI methods. The benefits of using AI to diagnose Alzheimer’s Disease.
Nanotechnology is a very promising field to the medicinal and pharmaceutical sectors, hence, it plays an important role in enhancing humanity’s quality of life. Nanotechnology has many applications in the medical sector, including diagnosis and therapeutic. However, therapeutic uses are considered the...
Moreover, Bosutinib shifted the macrophagic response from M1 to M2, and decreased pro-inflammatory cytokines production [69]. Bosutinib and Nilotinib were also used and compared in a murine model of Alzheimer’s disease (where brain plaques are considered a consequence of hyper-inflammation). In ...
E Rosenich is supported by an NHMRC Boosting Dementia Research Initiative grant (GNT1171816) and an Alzheimer's Association Research Fellowship (23AARF-1025519). Open Access funding enabled and organized by CAUL and its Member Institutions. Conflict of interest disclosure: On behalf of all authors,...